CKD 342

Drug Profile

CKD 342

Alternative Names: CKD-342; Mometasone furoate/levocabastine hydrochloride - Chong Kun Dang

Latest Information Update: 02 Jan 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chong Kun Dang
  • Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antihistamines; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists; Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Perennial allergic rhinitis

Most Recent Events

  • 01 May 2016 Chong Kun Dang completes a phase III trial in Perennial allergic rhinitis in South Korea (unspecified route) (NCT02498509)
  • 01 Jul 2015 Phase-III clinical trials in Perennial allergic rhinitis in South Korea (unspecified route) (NCT02498509)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top